<DOC>
	<DOC>NCT00316459</DOC>
	<brief_summary>To assess the effect of ERB-041 after multiple oral doses on cardiac repolarization as assessed by the QTc interval.</brief_summary>
	<brief_title>Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Long QT Syndrome</mesh_term>
	<criteria>Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and ECG. Nonsmoker or smoker of fewer than 10 cigarettes (half a pack) per day as determined by history. A family history of long QT syndrome and/or cardiac death. Any significant cardiovascular, hepatic, renal, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematological, neurological, or psychiatric disease.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Cardiac</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>